stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. SNN
    stockgist
    HomeTop MoversCompaniesConcepts
    SNN logo

    Smith & Nephew plc

    SNN
    NYSE
    Healthcare
    Medical - Devices
    Watford, GB17,349 employeessmith-nephew.com
    $32.13
    +0.04(0.11%)

    Mkt Cap $13.7B

    $24.97
    $38.70

    52-Week Range

    At a Glance

    AI-generated

    Smith & Nephew plc reported FY 2025 revenue of $6.16B, up 6.1% YoY from $5.81B, driven by 5.3% underlying growth across all three segments: Orthopaedics at $2.44B (+5.7%), Sports Medicine & ENT at $1.93B (+6.0%), and Advanced Wound Management at $1.79B (+6.7%).

    6-K
    Smith & Nephew plc granted share awards to its executive directors and other persons discharging managerial responsibilities on April 1, 2026, under three separate equity compensation plans, with vesting conditions extending to March 2029.

    $13.7B

    Market Cap

    $3.1B

    Revenue

    $317M

    Net Income

    Employees17,349
    Fundamentals

    How The Business Makes Money

    Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

    Industry Medical - Devices
    Activity

    What Changed Recently

    Securities Issuance
    Apr 1, 2026

    Current Report on Form 6-K

    Securities Issuance
    Mar 31, 2026

    Current Report on Form 6-K

    Securities Issuance
    Mar 23, 2026

    Current Report on Form 6-K

    Securities Issuance
    Mar 23, 2026

    Current Report on Form 6-K

    Securities Issuance
    Mar 15, 2026

    Current Report on Form 6-K

    Company Profile
    CIK0000845982
    ISINUS83175M2052
    CUSIP83175M205
    Phone44 1923 477 100
    AddressBuilding 5, Watford, WD18 8YE, GB
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice